Kamada (KMDA) Goodwill & Intangibles (2020 - 2026)
Kamada's (KMDA) quarterly Goodwill & Intangibles came in at $126.0 million in Q1 2026, down 4.36% YoY from $131.7 million in Q1 2025, and down 1.44% on a QoQ basis from $127.8 million in Q4 2025.
Kamada (KMDA) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Kamada (KMDA) has 7 years of Goodwill & Intangibles data on file, last reported at $126.0 million in Q1 2026.
- Quarterly Goodwill & Intangibles fell 4.36% year-over-year to $126.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $126.0 million (down 4.36% YoY) and the FY2025 annual result came in at $127.8 million, up 23.83% from the prior year.
- Goodwill & Intangibles fell to $126.0 million in Q1 2026, from $127.8 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $151.9 million in Q1 2022 to a low of $138623.0 in Q1 2024.
- A 5-year average of $108.0 million and a median of $129.5 million in 2025 frame the typical range for Goodwill & Intangibles.
- The widest YoY moves for Goodwill & Intangibles: up 95782.79% in 2023, down 99.9% in 2023.
- Tracing KMDA's Goodwill & Intangibles over 5 years: stood at $147.1 million in 2022, then decreased by 4.49% to $140.5 million in 2023, then declined by 26.51% to $103.2 million in 2024, then gained by 23.83% to $127.8 million in 2025, then slipped by 1.44% to $126.0 million in 2026.
- The last three Goodwill & Intangibles figures came in at $126.0 million (Q1 2026), $127.8 million (Q4 2025), and $129.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Kamada | 459.44 Mn | 429.97 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 124.28 Mn |
| Mar 31, 2026 | 125.99 Mn |
| Dec 31, 2025 | 127.82 Mn |
| Sep 30, 2025 | 129.50 Mn |
| Jun 30, 2025 | 99.64 Mn |
| Mar 31, 2025 | 131.74 Mn |
| Dec 31, 2024 | 103.23 Mn |
| Sep 30, 2024 | 135.04 Mn |
| Jun 30, 2024 | 106.52 Mn |
| Mar 31, 2024 | 138,623.00 |
| Dec 31, 2023 | 140.47 Mn |
| Sep 30, 2023 | 142.50 Mn |
| Jun 30, 2023 | 143.99 Mn |
| Mar 31, 2023 | 145,305.00 |
| Dec 31, 2022 | 147.07 Mn |
| Sep 30, 2022 | 148,620.00 |
| Jun 30, 2022 | 150.45 Mn |
| Mar 31, 2022 | 151.86 Mn |
| Dec 31, 2021 | 153.66 Mn |
| Sep 30, 2021 | 3.38 Mn |